https://charts.traderzeitung.de/phases/US4618741098 string(1388) "{"isin":"US4618741098","name":"EXoZymes Inc","stock_id_xnas":63386956,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.17,"close_at":"2026-09-21 21:58:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.27,"close_at":"2026-09-22 21:56:00","complete":true,"perf_pct":1.6207},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.11,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-2.5518},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

eXoZymes Aktie News & Nachrichten

[WKN: A40CGS | Symbol: EXOZ]

Realtimekurs

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über eXoZymes gefunden werden.

eXoZymes Nachrichtenticker öffnen

MT Newswires 08.06.2026 15:53 Uhr

EXoZymes preist 5,3 Millionen Dollar Platzierung ein

09:52 AM EDT, 06/08/2026 (MT Newswires) -- EXoZymes (EXOZ) hat den Preis für sein öffentliches Angebot von Einheiten, bestehend aus zwei Stammaktien u